Li J, Inoue R, .. Oyadomari S, Terauchi Y, *Shirakawa J. Imeglimin ameliorates β-cell apoptosis by modulating the endoplasmic reticulum homeostasis pathway. Diabetes. in press, 2021.（*責任著者：白川純）

*Shirakawa J. Translational research on human pancreatic β-cell mass expansion for the treatment of diabetes. Diabetol Int. 12(4):349-355, 2021.（*責任著者：白川純）

Minami T, Shirakawa J, Hiiragi H, Yamada T, Suzuki Y, Shirabe S, Maeda H, *Terauchi Y. Validity and reliability of the Japanese version of the Diabetes Knowledge Test among in-patients with type 2 diabetes. J Diabetes Investig. 13(3):580-587, 2022.

Terui S, Akamatsu R, Arai M, Inoue R, Okuyama T, Kyohara M, Li J, Tsuno T, Miyashita D, Togashi Y, Terauchi Y, *Shirakawa J. Immediate glucose-lowering effect after the first administration of dulaglutide: a retrospective, single-center, observational study. Diabetes Ther. 12(11):2873-2889, 2021. （*責任著者：白川純）

*Shirakawa J. Pancreatic β-cell fate in subjects with COVID-19. J Diabetes Investig. 12(12):2126-2128, 2021.（*責任著者：白川純）

Hasebe M, *Shirakawa J, Miyashita D, Kunishita R, Kyohara M, Okuyama T, Togashi Y, Terauchi Y. Asymptomatic meningitis diagnosed by positron emission tomography in a patient with syndrome of inappropriate antidiuretic hormone secretion: a case report. J Med Case Rep. 15(1):390, 2021.（*責任著者：白川純）

Okuyama T, Kyohara M, Terauchi Y, *Shirakawa J. The Roles of the IGF Axis in the Regulation of the Metabolism: Interaction and Difference between Insulin Receptor Signaling and IGF-I Receptor Signaling. Int J Mol Sci. 22(13):6817, 2021. （*責任著者：白川純）

Inoue R, Nishiyama K, Li J, Miyashita D, Ono M, Terauchi Y, *Shirakawa J. The Feasibility and Applicability of Stem Cell Therapy for the Cure of Type 1 Diabetes. Cells. 10(7):1589, 2021. （*責任著者：白川純）

#Takatani T, #Shirakawa J, #Shibue K, Gupta MK, Kim H, Lu S, Hu J, White MF, Kennedy RT, Kulkarni RN. Insulin receptor substrate 1 (IRS1), but not IRS2, plays a dominant role in regulating pancreatic alpha cell function in mice. J Biol Chem. 296:100646, 2021 （＃共筆頭著者：白川純）

Okuyama T, *Shirakawa J, Nakamura T, Murase T, Miyashita D, Inoue R, Kyohara M, Togashi Y, Terauchi Y. Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes. Sci Rep. 11(1):3768, 2021. （*責任著者：白川純）

Charoensuk C, Thamtarana PJ, Chanprasert C, Tangjittipokin W, Shirakawa J, Togashi Y, Orime K, Songprakhon P, Chaichana C, Abubakar Z, Ouying P, Sujjitjoon J, Doria A, Plengvidhya N, Yenchitsomanus PT. Autosomal Dominant Diabetes Associated with a Novel ZYG11A Mutation Resulting in Cell Cycle Arrest in Beta-Cells. Mol Cell Endocrinol. 522:111126, 2021. 

Gupta MK, Vethe H, Softic S, Rao TN, Wagh V, Shirakawa J, Barsnes H, Vaudel M, Takatani T, Kahraman S, Sakaguchi M, Martinez R, Hu J, Bjørlykke Y, Raeder H, *Kulkarni RN. Leptin Receptor Signaling Regulates Protein Synthesis Pathways and Neuronal Differentiation in Pluripotent Stem Cells. Stem Cell Reports. 15(5):1067-1079, 2020. 

Okuyama T, *Shirakawa J. .. Linagliptin Ameliorates Hepatic Steatosis via Non-Canonical Mechanisms in Mice Treated with a Dual Inhibitor of Insulin Receptor and IGF-1 Receptor. Int J Mol Sci. 21(21):E7815, 2020. （*責任著者：白川純）

Kyohara M, *Shirakawa J, Okuyama T, Togashi Y, Inoue R, Li J, Miyashita D, Terauchi Y. Soluble EGFR, a hepatokine, and adipsin, an adipokine, are biomarkers correlated with distinct aspects of insulin resistance in type 2 diabetes subjects. Diabetol Metab Syndr. 12:83, 2020.（*責任著者：白川純）

Wang H, Mizuno K, Takahashi N, Kobayashi E, Shirakawa J, Terauchi Y, Kasai H, Okunishi K, Izumi T. Melanophilin accelerates insulin granule fusion without predocking to the plasma membrane. Diabetes. 69(12):2655-2666, 2020.